MAAT-LOGOJuly 20, 2017: MaatPharma completes patient recruitment of its Odyssée clinical trial.

Within thirty months of its creation, Maat Pharma has reached the target number of patients to be treated in its first clinical trial, Odyssée. The biotech is testing the efficacy of its drug candidate, MaaT001.3, using Autologous Fecal Microbiota Transfer on patients suffering from Acute Myeloblastic Leukemia.

Press Release